Regulation of therapeutic goods in the United States

89/552/EEC of 3 October 1989 on the coordination of certain provisions laid down by Law, Regulation or Administrative Action in Member States concerning the pursuit

of ranitidine medicines in the EU. European Medicines Agency (EMA) (新闻稿). 30 April 2020 [2 June 2020]. （原始内容存档于2021-01-05）.  Ranitidine. Therapeutic Goods

[2021-04-16]. （原始内容存档于2021-04-22）.  Scheduling basics. 澳大利亞衛生部治療器物管理局（英语：Therapeutic Goods Administration）. [2020-10-18]. （原始内容存档于2021-04-22）.  Pharmacist-Only

2007-06-08 [7 June 2024].  Refixia (Novo Nordisk Pharmaceuticals Pty Ltd). Therapeutic Goods Administration (TGA). 13 September 2024 [2024-09-15].  Goodeve, A

Brochure: The History of Drug Regulation in the United States. （原始内容存档于2017-07-23）.  Tobert, Jonathan A. Lovastatin and beyond: the history of the HMG-CoA